2017 Compounding Packaging 
ISPE
MARCH 8, 2023
The cases covered the same types of contaminants and impurities noted in Table 1: microbial contaminants, process-related im-purities, metal contaminants, packaging-related contaminants, drug cross-contamination, and an “unknown” category encompassing other contaminants associated with the manufacturing process, including those from cell culturing.
The Checkup by Singlecare
SEPTEMBER 28, 2023
Though a 2017 literature review concluded there was no scientific evidence that inhaling hot and humidified air was helpful in relieving congestion caused by the common cold, Dr. Garcia-Ibáñez says steam helps humidify the nasal mucosa, and the more hydrated your secretions, the less nasal congestion you’ll experience.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
European Pharmaceutical Review
DECEMBER 21, 2022
Organic compounds are arguably the foundation of the pharmaceutical industry. All traditional small molecule pharmaceuticals include carbon building blocks” Organic compounds are arguably the foundation of the pharmaceutical industry. 349, 15 October 2017, pp. Molnár A, Papp A. Coordin Chem Rev, Vol.
The Checkup by Singlecare
JANUARY 9, 2024
Celery may have cardioprotective properties thanks to its abundance of bioactive compounds, some research suggests. Because celery is often packaged in plastic, the gas becomes trapped and accelerates this process. Prevention is multi-pronged, but eating a healthy diet rich in fruits and veggies like celery may help reduce the risks.
ISPE
OCTOBER 26, 2022
Tim Howard, who was Chair of the International Board from 2017–2018, helped by moderating the sessions. In addition, we took the Board on tours of Vetter’s facilities for sterile products and through all the production steps: compounding to fill-finish to automated visual inspection and secondary packaging. Thank you, Tim!
European Pharmaceutical Review
JUNE 24, 2022
The review was impacted by Brexit and the COVID-19 pandemic, which compounded existing issues surrounding high drug pricing and patient access that had been brewing since 2016 and highlighted several shortcomings in the EU’s pharmaceutical system. It is too early to say because we have not seen the whole package of measures yet.
pharmaphorum
AUGUST 25, 2021
When the news was getting out from China, our virologists in San Francisco were already scanning compounds, seeing which ones were the most effective. If you get past the regulatory hurdles, then you have to look at labelling requirements, packaging requirements, and quality assurance requirements.”. Growing with the times.
Expert insights. Personalized for you.
52 
Let's personalize your content